DNAG

Healthcare Biotechnology

DNAPrint Genomics, Inc.

$0.00
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
773,531.98
Avg Volume
0
52W High
$0.00
52W Low
$0.00
Div. Yield
0.0%

Valuation

P/B Ratio
-0.00
P/S Ratio
0.40
EV/EBITDA
-0.90
EV/Revenue
2.69
PEG Ratio
1.58

Margins

Gross Margin 23.1%
Operating Margin (730.6%)
Net Margin (235.6%)
EBITDA Margin (299.1%)

Growth & Returns

Revenue Growth (YoY)
(65.1%)
Return on Assets
(105.0%)

Liquidity & Leverage

Current Ratio
0.17
Quick Ratio
0.14
Total Cash
134,347
Total Debt
5.33M

About

DNAPrint Genomics, Inc. engages in the development and marketing of genetic testing products and services. It offers AncestryByDNA, a pan-chromosomal assay for genetic ancestry; EurasianDNA, which measures European sub-ancestry; EuropeanDNA, which reports a customer's proportional basic continental European ancestry; DNAWitness to determine genetic heritage from DNA samples obtained from crime scenes; RETINOME, which provides a physical portrait of a person of interest for a detective based on a DNA sample from a crime scene or remains of an individual; RETINOME, which allows infer eye color from DNA; and GenomeLab SNPstream Genotyping System, which offers genotyping rates and uses a multiplexing format to generate data with the minimum of reagents. The company serves forensic science, genealogical research, consumer products, and pharmaceutical development clients. DNAPrint Genomics, Inc. was formerly known as Lexington Energy, Inc. The company was incorporated in 1983 and is based in Sarasota, Florida with a subsidiary in Leverkusen, Germany.